Journal article icon

Journal article

Epidemiological Shifts in Visceral Leishmaniasis Incidence, Relapse, and Mortality in Brazil, 2007–2023: Analysis Using the National Notifiable Diseases Information System

Abstract:
Background: Brazil accounts for >90% of visceral leishmaniasis (VL) cases reported in South America. VL is a notifiable disease in Brazil and patient records are captured in the Sistema de Informação de Agravos de Notificação (SINAN) database. Methods: We reviewed 55 723 patient records from the SINAN system (2007–2023) to present temporal trends in patient demographics, drug regimens administered, and treatment outcomes. Disease incidence was modeled using a negative binomial regression, and predictors of mortality were assessed using logistic regression. Results: The VL incidence declined 6% annually (incidence rate ratio, 0.94 [95% confidence interval {CI}, 0.92–0.97]), primarily during 2019–2023. The median age at presentation was 10 years (interquartile range [IQR], 2–33 years) in 2007 and 32 years (IQR, 7–48 years) in 2023. The proportion of relapse at presentation also increased over time; compared to 2007–2009, the odds of relapse during 2019–2023 were 2.10-fold higher (95% CI, 1.87–2.37) adjusted for human immunodeficiency virus status. The use of liposomal amphotericin B increased markedly from 6.1% during 2007–2009 to 38.1% during 2019–2023, while antimony use declined from 68.0% to 32.7% over the same period. Following treatment, death from VL was highest among infants (<1y) (425/4125 [10.3%]) and those >50 years of age (1471/7615 [19.3%]), compared to the other age groups (3.5%, 2.2%, and 8.0% among ages ≥1 to <5, ≥5 to <15, and ≥15 to ≤50 years, respectively). Conclusions: The shift toward older patients and increased relapse at presentation indicates a major change in disease epidemiology in Brazil. These findings highlight the need for prioritizing interventions for older and relapsing patients.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1093/ofid/ofag035

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-9951-5762
More by this author
Role:
Author
ORCID:
0000-0003-0538-7403
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-5922-7539



Publisher:
Oxford University Press
Journal:
Open Forum Infectious Diseases More from this journal
Volume:
13
Issue:
2
Article number:
ofag035
Publication date:
2026-02-17
Acceptance date:
2025-12-17
DOI:
EISSN:
2328-8957
ISSN:
2328-8957


Language:
English
Keywords:
Pubs id:
2378817
Local pid:
pubs:2378817
Source identifiers:
3767161
Deposit date:
2026-02-17
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP